Federal: S4464

Bill Summary

The FAIR Labels Act of 2026 (US S4464) amends federal meat and poultry inspection laws to require clear labeling of cell-cultivated protein products and plant-based alternative protein products. Cell-cultivated proteins must be labeled "cell-cultivated" adjacent to the product name with a disclaimer that they are not derived from naturally produced meat or poultry. Plant-based alternatives must be labeled as "plant-based alternative protein product" with similar disclaimers. The bill directs the Secretary of Agriculture and Secretary of Health and Human Services to establish common standards of identity for both categories within 180 days of enactment and to revise their regulatory agreement to clarify USDA oversight of cell-cultivated production and FDA premarket review.

Why It Matters to MAHA

This bill directly advances MAHA's core commitment to transparency and informed consumer choice by requiring truthful, clear labeling of novel protein products. Consumers deserve to know exactly what they are purchasing and whether products are cell-cultivated, plant-based, or conventional meat—information that is currently ambiguous or absent in the marketplace. The bill does not restrict access to any protein technology; it simply mandates honest disclosure so patients and consumers can make autonomous decisions aligned with their health values and preferences. This aligns perfectly with MAHA's principle that health freedom requires transparency and that regulatory frameworks should empower rather than deceive the consumer.